Product: TOBRAMYCIN 1.4% (14MG/ML) OPHTHALMIC	15 ML  	3 ML  	  	7 ML;  	  	  TOBRAMYCIN SOLUTION** 0.3% OPHTHALMIC	30 MLS  	  	5 MLS;  TOBRAMYCIN SULFATE** (25X2ML) 80MG/2ML INJECTABLE	100 ML  	150 ML  	50 MLS;  TOBRAMYCIN/AMPHOTERICIN-B/BUDESONIDE, STERILE 125MG/5MG/0.6MG/5ML NASO-NEB	70 ML  (9 DIFFERENT PRODUCTS)
Reason for recall: Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Recall initiated: 20120521
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated